Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant

NCT01706666 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Stage I Multiple Myeloma
Stage II Multiple Myeloma
Stage III Multiple Myeloma

Interventions

DRUG: bortezomib
DRUG: cyclophosphamide
DRUG: lenalidomide
OTHER: laboratory biomarker analysis
DRUG: dexamethasone
PROCEDURE: quality-of-life assessment

Sponsor

Mayo Clinic